Flavonoids exert potential in the management of hypertensive disorders in pregnancy

Autoři	MAZURAKOVA Alena KOKLESOVA Lenka SAMEC Marek KUDELA Erik SIVAKOVA Jana PRIBULOVA Terezia PEC Martin Jozef PEC Martin KELLO Martin BUSSELBERG Dietrich GOLUBNITSCHAJA Olga GASPAR Ludovit CAPRNDA Martin ADAMEK Mariusz PROSECKÝ Robert EMINOVA Elmira BARANENKO Denis KRUŽLIAK Peter KUBATKA Peter BIRINGER Kamil
Rok publikování	2022
Druh	Článek v odborném periodiku
Časopis / Zdroj	PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
www	https://www.sciencedirect.com/science/article/pii/S2210778922000642?via%3Dihub
Doi	http://dx.doi.org/10.1016/j.preghy.2022.06.007
Klíčová slova	Flavonoids; Hypertensive disorders; Pregnancy; Preeclampsia
Popis	Hypertensive disorders in pregnancy represent severe complications of pregnancy, which, if not treated, can result in serious health consequences for the mother and the child. Flavonoids are bioactive secondary metabolites commonly found in fruits, vegetables, green tea, whole grains, and medicinal plants. Flavonoids exert potent protective efficacy in experimental models of hypertensive disorders in pregnancy, especially preeclampsia, demonstrated through their capacity to modulate inflammatory responses, oxidative stress, and vascular dysfunction. In addition to their potential as therapeutics, flavonoids or flavonoid-rich food could be helpful to decrease the risk of hypertensive disorders in pregnancy when included in the diet pattern before and during pregnancy. However, the clinical evaluation of the potential capacity of flavonoids in hypertensive disorders in pregnancy is insufficient. Due to promising results from experimental studies, we highlight the need for the evaluation of flavonoids also in an appropriate clinical setting, which can be, together with proper preventive strategies, helpful in the overall management of hypertensive disorders in pregnancy.